These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12573816)

  • 41. Inhibition of insulin- and insulin-like growth factor-I-stimulated growth of human breast cancer cells by 1,25-dihydroxyvitamin D3 and the vitamin D3 analogue EB1089.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; Birkenhäger JC; van Leeuwen JP
    Eur J Cancer; 1996 May; 32A(5):842-8. PubMed ID: 9081364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
    Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
    J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia.
    Mori F; Tanigawa K; Endo K; Minamiguchi K; Abe M; Yamada S; Miyoshi K
    Prostate; 2011 Oct; 71(14):1579-86. PubMed ID: 21394740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of apoptosis in human prostate stromal cells by 4-hydroxytamoxifen: an alternative therapy for benign prostate hyperplasia.
    Glienke W; Dolgova Y; Müller I; Grösch S; Binder J; Geisslinger G; Jonas D
    World J Urol; 2004 Dec; 22(6):452-6. PubMed ID: 15448996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta.
    Huang X; Lee C
    Front Biosci; 2003 Sep; 8():s740-9. PubMed ID: 12957826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia.
    Sreenivasulu K; Nandeesha H; Dorairajan LN; Rajappa M; Vinayagam V; Cherupanakkal C
    Aging Male; 2018 Jun; 21(2):138-144. PubMed ID: 29129118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Androgen responsiveness of stromal cells of the human prostate: regulation of cell proliferation and keratinocyte growth factor by androgen.
    Planz B; Wang Q; Kirley SD; Lin CW; McDougal WS
    J Urol; 1998 Nov; 160(5):1850-5. PubMed ID: 9783973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in localized, metastasized prostate cancer and benign prostatic hyperplasia.
    Aksoy Y; Aksoy H; Bakan E; Atmaca AF; Akçay F
    Urol Int; 2004; 72(1):62-5. PubMed ID: 14730168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin D and benign prostatic hyperplasia -- a review.
    Espinosa G; Esposito R; Kazzazi A; Djavan B
    Can J Urol; 2013 Aug; 20(4):6820-5. PubMed ID: 23930605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulative effect of transforming growth factor-beta on collagen synthesis by human prostatic stromal cells in vitro.
    Fukabori Y; Nakano K; Ohyama A; Yamanaka H
    Int J Urol; 1997 Nov; 4(6):597-602. PubMed ID: 9477191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
    Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
    Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat model.
    Chen KC; Sung SY; Lin YT; Hsieh CL; Shen KH; Peng CC; Peng RY
    BMC Urol; 2015 Nov; 15():113. PubMed ID: 26576637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated insulin and reduced insulin like growth factor binding protein-3/prostate specific antigen ratio with increase in prostate size in Benign Prostatic Hyperplasia.
    Sreenivasulu K; Nandeesha H; Dorairajan LN; Rajappa M; Vinayagam V
    Clin Chim Acta; 2017 Jun; 469():37-41. PubMed ID: 28300542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Influence of androgen on Bcl-2 mRNA expression in BPH tissue].
    Wang X; Ye H; Jiang H; Xu Q; Zhu J; Hou S
    Zhonghua Wai Ke Za Zhi; 2000 Mar; 38(3):198-200. PubMed ID: 11832028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of keratinocyte growth factor on cell viability in primary cultured human prostate cancer stromal cells.
    Huang YW; Wang LS; Chang HL; Ye W; Shu S; Sugimoto Y; Lin YC
    J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):24-33. PubMed ID: 16854582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia.
    Colombel M; Vacherot F; Diez SG; Fontaine E; Buttyan R; Chopin D
    Br J Urol; 1998 Sep; 82(3):380-5. PubMed ID: 9772874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of the stromal microenvironment in carcinogenesis of the prostate.
    Cunha GR; Hayward SW; Wang YZ; Ricke WA
    Int J Cancer; 2003 Oct; 107(1):1-10. PubMed ID: 12925950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.
    Dahiya R; Lee C; Haughney PC; Chui R; Ho R; Deng G
    Urology; 1996 Dec; 48(6):963-70. PubMed ID: 8973690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
    Mannowetz N; Würdinger R; Zippel A; Aumüller G; Wennemuth G
    Prostate; 2010 Sep; 70(12):1350-8. PubMed ID: 20623639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH).
    Quiles MT; Arbós MA; Fraga A; de Torres IM; Reventós J; Morote J
    Prostate; 2010 Jul; 70(10):1044-53. PubMed ID: 20503393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.